在线岛国大香蕉,秋霞在线视频国产视频

xum***xia 2018-10-31 09:46 IP：未知

◆◆

文獻(xiàn)標(biāo)題： 1："kidney Int. 2015 Jul;88(1):17-27. doi: 10.1038/ki.2015.59. Epub 2015 Mar 18. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Chapman AB1, Devuyst O2, Eckardt KU3, Gansevoort RT4, Harris T5, Horie S6, Kasiske BL7, Odland D8, Pei Y9, Perrone RD10, Pirson Y11, Schrier RW12, Torra R13, Torres VE14, Watnick T15, Wheeler DC16; Conference Participants." 2："Kidney Int. 2015 Oct;88(4):676-83. doi: 10.1038/ki.2015.28. Epub 2015 Mar 4. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report. Eckardt KU1, Alper SL2, Antignac C3,4, Bleyer AJ5, Chauveau D6, Dahan K7, Deltas C8, Hosking A9, Kmoch S10, Rampoldi L11, Wiesener M1, Wolf MT12, Devuyst O13; Kidney Disease: Improving Global Outcomes." 3：alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 1 trials.the lan lancet et oncology. 4：Topical treatment of glaucoma: established and emerging pharmacology 5：Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. [更多]

特色服務(wù)>>文獻(xiàn)檢索

懸賞：￥50.00

㖃特色服務(wù)>>文獻(xiàn)檢索

懸賞

￥50.00

已托管

載入中...

3

xum***xia 2018-11-07 09:53 IP：未知

◆◆

求購(gòu)文獻(xiàn)數(shù)篇

1、Analytical method transfer using equivalence tests with reasonable acceptance criteria and appropriate effort: extension of the ISPE concept 2、Using total error as decision criterion in analytical method transfer 3、Application of the equivalence test according to a concept for analytical method transfers from the International Society for Pharmaceutical Engineering (ISPE) 4、Application of the equivalence test for analytical method transfers: Testing precision using the United States Pharmacopoeia concept< 1 0 1 0 5、Blade-Font, Artur; Rocabayera, Teodoro de Mas - [Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1982, p. 841 - 848] [更多]

特色服務(wù)>>文獻(xiàn)檢索

懸賞：￥50.00

㖃特色服務(wù)>>文獻(xiàn)檢索

懸賞

￥50.00

已托管

載入中...

1

xia***888 2018-11-13 15:43 IP：通化

◆◆

求購(gòu)“NFMonographs:rAlbuminHuman”《USP41-NF36》的藥典信息一份.

PDF 版即可 [更多]

特色服務(wù)>>文獻(xiàn)檢索

懸賞：￥50.00

㖃特色服務(wù)>>文獻(xiàn)檢索

懸賞

￥50.00

已托管

載入中...

3

yyy***738 2018-11-28 08:27 IP：長(zhǎng)沙

◆◆

求購(gòu)“Macrogol4000.”《EP9.1》的藥典信息一份.

求購(gòu)聚乙二醇4000 EP9.1標(biāo)準(zhǔn)一份 [更多]

特色服務(wù)>>文獻(xiàn)檢索

懸賞：￥50.00

㖃特色服務(wù)>>文獻(xiàn)檢索

懸賞

￥50.00

已托管

載入中...

3

whe***hid 2018-12-04 11:42 IP：北京

◆◆

求購(gòu)“FormulatedPreparations:SpecificMonographs:AmlodipineBesilateTablets”《BP2019》的藥典信息一份.

求購(gòu)“Formulated Preparations: Specific Monographs: Amlodipine Besilate Tablets”《 BP2019 》的藥典標(biāo)準(zhǔn)一份. [更多]

特色服務(wù)>>文獻(xiàn)檢索

懸賞：￥50.00

㖃特色服務(wù)>>文獻(xiàn)檢索

懸賞

￥50.00

已托管

載入中...

1

xum***xia 2018-11-29 10:44 IP：未知

◆◆

求購(gòu)文獻(xiàn)數(shù)篇

文獻(xiàn)標(biāo)題及相關(guān)信息如下： 1.Safety data for chemical products-Content and order of sections［s］． ISO 11014-2009， 2009 2.ZHANG Li， LU Ying． Problems incountering for danger chemicals registing work in Jiangsu［J］． Chemical Safety ＆ Environment，2007， 1( 12) : 8-12 3.EU， Regulation( EC) No 1272 /2008 of European Parliament and of the Council of 16 December 2008 on classification， labelling and packing of substances and amending Regulation( EC) No1907 /2006［z］， 2008 4.Hazard Communication． 29 CFR 1910. 1200 5.SHA Xi-dong，JIANG Hong， LI Li-xia． Study on classification of major hazard installation of hazardous chemicals［J］． Journal of Safety Science and Technology， 2011，7 ( 3) : 37-41 備注：提供PDF電子檔原件 [更多]

特色服務(wù)>>文獻(xiàn)檢索

懸賞：￥50.00

㖃特色服務(wù)>>文獻(xiàn)檢索

懸賞

￥50.00

已托管

載入中...

1

che***018 2018-12-03 12:25 IP：上海

◆◆

求購(gòu)“RanitidineTablets”《BP2017》的藥典信息一份.

標(biāo)題：Ranitidine Tablets”《 BP2017 》的藥典標(biāo)準(zhǔn)一份. 詳細(xì)要求：需求名稱：Ranitidine Tablets”《 BP2017 》的藥典標(biāo)準(zhǔn)一份. 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會(huì)每天過(guò)來(lái)看的，謝謝各位藥智的戰(zhàn)友們 [更多]

特色服務(wù)>>文獻(xiàn)檢索

懸賞：￥50.00

㖃特色服務(wù)>>文獻(xiàn)檢索

懸賞

￥50.00

已托管

載入中...

5

dlz***666 2018-12-11 09:50 IP：西安

◆◆

求購(gòu)“Betadex”《EP9.2》的藥典信息一份.

倍他環(huán)糊精最新的歐洲藥典至少是EP9.2 [更多]

特色服務(wù)>>文獻(xiàn)檢索

懸賞：￥50.00

㖃特色服務(wù)>>文獻(xiàn)檢索

懸賞

￥50.00

已托管

載入中...

3

hon***981 2018-12-12 10:05 IP：本溪

◆◆

求購(gòu)“Levocarnitine”《EP9.6》的藥典信息一份.

Levocarnitine ”《 EP9.6 》的藥典標(biāo)準(zhǔn)一份. [更多]

特色服務(wù)>>文獻(xiàn)檢索

懸賞：￥50.00

㖃特色服務(wù)>>文獻(xiàn)檢索

懸賞

￥50.00

已托管

載入中...

1

xum***xia 2018-12-17 16:54 IP：未知

◆◆

求購(gòu)文獻(xiàn)數(shù)篇

文獻(xiàn)標(biāo)題及相關(guān)信息 1：Fluconazole-related hepatotoxicity in patients with acquired immunodeficiency syndrome 2：Tohno, M.，Konishi , Y.，Kojima , H., Kawahara, K. and Horiba, M. (1992 ) Pharmacokinetics and metabolic studies of LFP83 in man after the single and repeated intravenous administration. Clin. Rep. 26, 3907-3921. 3：Targeting Vascular Endothelial-?Cadherin in Tumor-?Associated Blood Vessels Promotes T-?cell-?Mediated Immunotherapy 4：Therapeutic regulation of VE-?cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models [更多]

特色服務(wù)>>文獻(xiàn)檢索

懸賞：￥50.00

㖃特色服務(wù)>>文獻(xiàn)檢索

懸賞

￥50.00

已托管

載入中...

1

国产又大又粗又长,美女在线视频亚洲蜜桃,一区二区不卡的黄色,日韩精品码人妻,大鸡巴操逼国产视频,人妻系列在线播放,亚洲特色黄大片,亚洲AV四区,夜夜操综合

㔍我要出現(xiàn)在這里
推薦任務(wù)

国产又大又粗又长,美女在线视频亚洲蜜桃,一区二区不卡的黄色,日韩精品码人妻,大鸡巴操逼国产视频,人妻系列在线播放,亚洲特色黄大片,亚洲AV四区,夜夜操综合

當(dāng)前位置：  首頁(yè) > 需求大廳 > 特色服務(wù)  > 文獻(xiàn)檢索 

㔍我要出現(xiàn)在這里 推薦任務(wù)

當(dāng)前位置：  首頁(yè) > 需求大廳
> 特色服務(wù) 

> 文獻(xiàn)檢索 

㔍我要出現(xiàn)在這里
推薦任務(wù)